Carlo Tur

1.4k total citations · 2 hit papers
10 papers, 87 citations indexed

About

Carlo Tur is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Carlo Tur has authored 10 papers receiving a total of 87 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Immunology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Carlo Tur's work include CAR-T cell therapy research (6 papers), Systemic Sclerosis and Related Diseases (3 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Carlo Tur is often cited by papers focused on CAR-T cell therapy research (6 papers), Systemic Sclerosis and Related Diseases (3 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Carlo Tur collaborates with scholars based in Germany, Italy and Japan. Carlo Tur's co-authors include Maria Gabriella Raimondo, Georg Schett, Melanie Hagen, Markus Eckstein, Andreas Wirsching, Ricardo Grieshaber‐Bouyer, Laura Bucci, Aline Bözec, Filippo Fagni and Artur Wilhelm and has published in prestigious journals such as Nature Medicine, Annals of the Rheumatic Diseases and RMD Open.

In The Last Decade

Carlo Tur

6 papers receiving 86 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bispecific T cell engager therapy for refractory rheumatoid arthritis

2024 67 citations Laura Bucci, Melanie Hagen et al. Nature Medicine profile →
BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells

2025 15 citations Fabian Müller, Andreas Wirsching et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carlo Tur Germany	3	42	39	23	13	11	10	87
Artur Wilhelm Germany	4	57 1.4×	46 1.2×	31 1.3×	21 1.6×	13 1.2×	4	104
Jasmin Ristenpart Germany	5	53 1.3×	30 0.8×	18 0.8×	8 0.6×	17 1.5×	5	120
Gerulf Hänel Germany	5	53 1.3×	39 1.0×	12 0.5×	17 1.3×	21 1.9×	15	92
Sascha Kretschmann Germany	5	56 1.3×	79 2.0×	10 0.4×	11 0.8×	25 2.3×	8	109
Aida Ferreiro-Iglesias Spain	7	20 0.5×	28 0.7×	59 2.6×	9 0.7×	19 1.7×	9	109
Alba Garrido-Trigo Spain	3	26 0.6×	35 0.9×	14 0.6×	3 0.2×	13 1.2×	5	75
Ella Sorani United States	6	45 1.1×	44 1.1×	6 0.3×	8 0.6×	16 1.5×	21	100
Kaitlyn A. Lagattuta United States	4	96 2.3×	39 1.0×	16 0.7×	19 1.5×	40 3.6×	7	143
Marion Moreews France	3	116 2.8×	22 0.6×	47 2.0×	12 0.9×	24 2.2×	4	139
Ryochi Yoshida Japan	7	37 0.9×	7 0.2×	48 2.1×	8 0.6×	11 1.0×	11	99

Countries citing papers authored by Carlo Tur

Since Specialization

Citations

This map shows the geographic impact of Carlo Tur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Tur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Tur more than expected).

Fields of papers citing papers by Carlo Tur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlo Tur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Tur. The network helps show where Carlo Tur may publish in the future.

Co-authorship network of co-authors of Carlo Tur

This figure shows the co-authorship network connecting the top 25 collaborators of Carlo Tur. A scholar is included among the top collaborators of Carlo Tur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlo Tur. Carlo Tur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Rizzo, Chiara, Enrico De Lorenzis, Ingrid Möller, et al.. (2025). Minimally invasive ultrasound-guided biopsy of the common extensor tendon enthesis: a cadaveric study to standardise the technique. RMD Open. 11(2). e005328–e005328.

2.

Müller, Fabian, Andreas Wirsching, Melanie Hagen, et al.. (2025). BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells. Nature Medicine. 31(6). 1793–1797. 15 indexed citations breakdown →

3.

Tur, Carlo, Markus Eckstein, Simon Rauber, et al.. (2025). Reply to Correspondence on: ‘Effects of different B-cell-depleting strategies on the lymphatic tissue’. Annals of the Rheumatic Diseases. 85(1). e1–e2. 1 indexed citations

4.

Bucci, L., Melanie Hagen, Carlo Tur, et al.. (2025). ABS0364 SAFETY AND EFFICACY OF T CELL ENGAGER THERAPY IN PATIENTS WITH REFRACTORY AUTOIMMUNE DISEASE. Annals of the Rheumatic Diseases. 84. 1510–1511.

5.

Bucci, Laura, Melanie Hagen, Tobias Rothe, et al.. (2024). Bispecific T cell engager therapy for refractory rheumatoid arthritis. Nature Medicine. 30(6). 1593–1601. 67 indexed citations breakdown →

6.

Müller, Fabian, Filippo Fagni, Christina Bergmann, et al.. (2024). OP0027 LONG-TERM SAFETY AND EFFICACY OF CAR-T CELL TREATMENT IN SEVERE AND TREATMENT REFRACTORY AUTOIMMUNE DISEASE. Annals of the Rheumatic Diseases. 83. 137–137. 2 indexed citations

7.

Schett, Georg, Franco B. Mueller, Melanie Hagen, et al.. (2024). POS0030 SAFETY AND PRELIMINARY EFFICACY OF CD19 CAR-T CELL TREATMENT IN RHEUMATIC DISEASE- DATA FROM THE FIRST PART OF THE PHASE I/II CASTLE BASKET STUDY. Annals of the Rheumatic Diseases. 83. 327–327. 1 indexed citations

8.

Bucci, L., Fabian Müller, Melanie Hagen, et al.. (2024). POS0340 EFFECTS OF CAR-T CELL TREATMENT ON B CELL IMMUNITY IN SYSTEMIC AUTOIMMUNE DISEASES. Annals of the Rheumatic Diseases. 83. 265–266.

9.

Müller, Fabian, Simon Völkl, L. Bucci, et al.. (2024). OP0320 EFFICACY OF CD19-TARGETING CAR T CELL TREATMENT IN PATIENTS WITH DIFFUSE SYSTEMIC SCLEROSIS (dSSc) – AN OPEN LABEL, SINGLE-CENTER PILOT STUDY. Annals of the Rheumatic Diseases. 83. 204–205. 1 indexed citations

10.

Bucci, L., Melanie Hagen, Carlo Tur, et al.. (2024). OP0193 BITEING MULTI-DRUG RESISTANT RHEUMATOID ARTHRITIS WITH CD19-T CELL ENGAGERS. Annals of the Rheumatic Diseases. 83. 102–102.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact